| Literature DB >> 23612154 |
Carlos Parra1, Francisco Jódar-Sánchez, M Dolores Jiménez-Hernández, Eduardo Vigil, Alfredo Palomino-García, Francisco Moniche-Álvarez, Francisco Javier De la Torre-Laviana, Patricia Bonachela, Francisco José Fernández, Aurelio Cayuela-Domínguez, Sandra Leal.
Abstract
BACKGROUND: Health care service based on telemedicine can reduce both physical and time barriers in stroke treatments. Moreover, this service connects centers specializing in stroke treatment with other centers and practitioners, thereby increasing accessibility to neurological specialist care and fibrinolytic treatment.Entities:
Keywords: Fibrinolysis; Standardization; Stroke; Telemedicine
Year: 2012 PMID: 23612154 PMCID: PMC3626126 DOI: 10.2196/ijmr.2163
Source DB: PubMed Journal: Interact J Med Res ISSN: 1929-073X
Information systems at the two requesting hospitals.
| Features | San Juan de Dios Hospital | José María Díaz Domínguez Hospital |
| HISa | HIS ACTICX Telvent Interactive 4.1. HL7 communication. HL7 communication. | Aurora from SIEMENS, version 3.0.78. HL7 communication. HL7 communication. |
| LISb | OpenLAB from Icon Media Lab. HL7 communication. HL7 communication. | Omega 2000 from ROCHE version 2.02.00.b. HL7 communication. HL7 communication. |
| RISc | PHILIPS. HL7 communication. HL7 communication. | Telvent GESIR 3.0. |
| PACSd | PACS from PHILLIPS. DICOM communication. DICOM communication. | PACS from Telvent. DICOM communication. DICOM communication. |
| Security and authentication | Firewall. They currently have an Active Directory | Firewall. Rt domain. |
| Communications | Symmetric communication with Corporate Network through MACROLAN, 2 Mbps | Symmetric communication with Corporate Network via 100Mb Optical Fibre MetroLAN and 2MB Reinforced Copper MetroLan |
a Hospital Information System.
b Laboratory Information System.
c Radiology Information System.
d Picture Archiving and Communication Systems.
Figure 1Data hierarchy from TeleStroke medical station.
Figure 2Computerized tomography image.
Characteristics of patients; data are presented as n (%).
|
| No Fibrinolysis | Fibrinolysis | |
| Age | 40 – 49 | 2 (22.2) | 3 (15.8) |
|
| 50 – 59 | 2 (22.2) | 1 (5.0) |
|
| 60 – 69 | 1 (11.1) | 4 (21.0) |
|
| 70 – 80 | 4 (44.4) | 11 (58.2) |
| Sex | Females | 3 (33.3) | 10 (52.6) |
|
| Males | 6 (66.7) | 9 (47.4) |
| Origina | Own decision | 3 (33.3) | 6 (35.3) |
|
| Health center | 3 (33.3) | 4 (23.5) |
|
| Emergency department | 0 (0) | 1 (5.9) |
|
| MICUb | 3 (33.3) | 7 (35.3) |
| Displacement of the patient | Own vehicle | 4 (44.4) | 7 (36.8) |
|
| Ambulance | 5 (55.6) | 12 (63.2) |
a There are values missing for these variables.
b MICU: Mobile Intensive-Care Unit.
Indicators in process of fibrinolysis delivery.
|
| Min-Max | Mean ± SD | |
|
|
|
|
|
|
| Onset-to-hospital | 15-155 | 68.68 ± 41.76 |
|
| Door-to-needle | 33-128 | 81.89 ± 28.29 |
|
| Admission-to-CT scan | 6-85 | 32.87 ± 19.11 |
|
| Onset-to-needle | 70-210 | 150.58 ± 38.61 |
Characteristics of medical professionals who have used TeleStroke; data are presented as n (%).
| Categories | SJDH | JMDDH | VRUH | Total | |
| Sex | Females | 6 (17.6) | 1 (2.9) | 6 (17.6) | 13 (38.2) |
|
| Males | 13 (38.2) | 3 (8.8) | 5 (14.7) | 21 (61.8) |
| Age | <40 | 9 (26.4) | 1 (2.9) | 8 (23.5) | 18 (52.9) |
|
| 40-49 | 9 (26.4) | 2 (5.9) | 2 (5.9) | 13 (38.2) |
|
| ≥50 | 1 (2.9) | 1 (2.9) | 1 (2.9) | 3 (8.8) |
| Clinical practice years | <10 | 2 (5.9) | - | 5 (14.7) | 7 (20.6) |
|
| 10-19 | 17 (50.0) | 3 (8.8) | 4 (11.7) | 24 (70.6) |
|
| ≥20 | - | 1 (2.9) | 2 (5.9) | 3 (8.8) |
| Medical speciality | Family doctors | 7 (20.6) | - | - | 7 (20.6) |
|
| Internists | 9 (26.5) | - | - | 9 (26.5) |
|
| Intensivists | 3 (8.8) | 4 (11.7) | - | 7 (20.6) |
|
| Neurologists | - | - | 11 (32.3) | 11 (32.3) |
| Experience with TeleStroke | Knowledge/training courses | 6 (17.6) | - | 2 (5.9) | 8 (23.5) |
|
| Clinical case | 13 (38.2) | 4 (11.7) | 9 (26.5) | 26 (76.5) |
Descriptive statistics of the TAM questionnaire item.
| Items | Min-Max | Mean ± SD | |
|
|
|
|
|
|
| TS could enhance my effectiveness of job | 1-10 | 7.35 ± 2.06 |
|
| TS would allow greater control over DTPa | 1-10 | 7.68 ± 1.98 |
|
| TS could support critical aspects in DTP | 3-10 | 8.18 ± 1.80 |
|
| If I use TSb, I will increase my chances to develop my career | 1-10 | 7.06 ± 2.36 |
|
| Using TS would make my job easier | 1-10 | 6.62 ± 2.62 |
|
| Using TS would improve my job performance | 1-10 | 7.32 ± 2.03 |
|
| Using TS would help me to accomplish DTP more quickly | 1-10 | 6.97 ± 2.89 |
|
| TS could improve the quality of DTP that I deliver | 3-10 | 7.82 ± 1.87 |
|
| Overall, TS could be useful to improve DTP | 1-10 | 8.06 ± 1.98 |
|
|
|
|
|
|
| Learning to use TS would be easy for me | 4-10 | 7.56 ± 1.71 |
|
| My interaction with TS would be clear and understandable | 3-10 | 7.09 ± 1.91 |
|
| I think that DTP made through TS would be clear | 3-10 | 7.82 ± 1.80 |
|
| It would be easy for me to become skillful at using TS | 4-10 | 7.21 ± 1.74 |
|
| Overall, I believe that TS will be easy to use | 2-10 | 6.65 ± 2.14 |
|
|
|
|
|
|
| Colleagues whose opinions I value think I should use TS | 3-10 | 7.91 ± 1.91 |
|
| My superiors think that I should use TS | 8-10 | 9.47 ± 0.75 |
|
| Other health professionals whose opinions I value think I should use TS | 3-10 | 7.91 ± 1.90 |
|
| The management of the hospital supports me to use TS | 2-10 | 9.03 ± 1.66 |
|
| Overall, I believe that the hospital supports the use of TS | 5-10 | 8.94 ± 1.32 |
|
|
|
|
|
|
| A specific person will be available to solve problems regarding to TS | 1-10 | 6.65 ± 2.00 |
|
| I will have the resources necessary to use TS | 3-10 | 7.94 ± 1.84 |
|
| I will receive training to use TS | 2-10 | 7.12 ± 2.21 |
|
| TS will be compatible with other systems I use | 4-10 | 8.18 ± 1.58 |
|
| The hospital has the infrastructure necessary to I use TS | 4-10 | 7.91 ± 1.83 |
|
|
|
|
|
|
| I intend to use TS as it is available in the hospital | 4-10 | 9.03 ± 1.55 |
|
| I intend to use TS for DTP as often as needed | 4-10 | 8.97 ± 1.42 |
|
| Whenever possible, I intend to use TS | 3-10 | 8.82 ± 1.73 |
a TS: TeleStroke.
b DTP: diagnosis and treatment of patients.